Australia, Feb. 10 -- Roche Diagnostics Gmbh, owns the trademark (2605253) for 'LUMIRADX' till Oct. 20, 2035.
Status: protected:
Registered/protected
Classes: 5 [Chemical preparations for medical purposes; biological preparations for medical purposes; biochemical preparations for medical use; in vitro diagnostic preparations for medical use; diagnostic reagents for medical use; reagents for in-vitro laboratory use [for medical purposes]; diagnostic biomarker reagents for medical purposes.] and 9 [Bio-sensors; biochip sensors; barcode scanners; bar code printers; portable scanners; radio-frequency identification (RFID) tags; application software for cloud computing services; bags adapted for laptops; cases for tablet computers; cases for data storage devices; computer software for use in medical decision support systems; workflow management system software; software as a medical device [SaMD], downloadable; application software for mobile devices, all the aforesaid goods related to the field of in vitro diagnostics.]
Type of Mark: Word
Date of Acceptance: Dec. 2, 2025
Registration Advertised: Feb. 9
For further details contact F. Hoffmann-La Roche AG .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2605253.
Disclaimer: Curated by HT Syndication.
